A number of gene alterations, such as point mutations in RAS and BRAF genes, point mutations or amplification of PIK3CA, and fusion genes involving RET, NTRK1 and PPARγ are known to frequently occur in differentiated thyroid carcinoma [6,13], and are correlated to different morphological subtypes. This evidence concerns the gene NTRK1 and differentiated thyroid carcinoma.